Targeting HIF-Hydroxylases Compromises Disease Initiation and Propagation, and Synergises with Current Therapies to Eliminate Cancer Stem Cells in AML von Lawson, Hannah, Holt-Martyn, James, Dembitz, Vilma, Durko, Jozef, Kabayama, Yuka, Wang, Lydia, Van De Lagemaat, Louie, Dubusse, Louis, Alunno, Laura, Guitart, Amelie, Schwaller, Jürg, Gallipoli, Paolo, O'Carroll, Dónal, Schofield, Christopher, Kranc, Kamil

Volltext

The selective prolyl hydroxylase inhibitor IOX5 stabilizes HIF-1α and compromises development and progression of acute myeloid leukemia von Lawson, Hannah, Holt-Martyn, James P, Dembitz, Vilma, Kabayama, Yuka, Wang, Lydia M, Bellani, Aarushi, Atwal, Samanpreet, Saffoon, Nadia, Durko, Jozef, van de Lagemaat, Louie N, De Pace, Azzura L, Tumber, Anthony, Corner, Thomas, Salah, Eidarus, Arndt, Christine, Brewitz, Lennart, Bowen, Matthew, Dubusse, Louis, George, Derek, Allen, Lewis, Guitart, Amelie V, Fung, Tsz Kan, So, Chi Wai Eric, Schwaller, Juerg, Gallipoli, Paolo, O'Carroll, Donal, Schofield, Christopher J, Kranc, Kamil R

Volltext